Tea flavonoids and cardiovascular diseases: A review

Critical Reviews in Food Science and Nutrition

Volumn 37, Issue 8, 1997, Pages 771-785

  Tijburg, L B M ^a   Mattern, T ^b   Folts, J D ^b   Weisgerber, U M ^a   Katan, M B ^c  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; LIPID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECT; HEMOSTASIS; HUMAN; LIPID PEROXIDATION; METABOLISM; REVIEW; TEA;

ANIMALS; CARDIOVASCULAR DISEASES; FLAVONOIDS; HEMOSTASIS; HUMANS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, LDL; TEA;

EID: 0031306997     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408399709527802     Document Type: Article

References (93)

1. Alcaraz M.J., Villar A. Anti-inflammatory activity of natural phenolic compounds. 1989. In: Handbook of Free Radicals andAntioxidants in Biomedicine. pp. 77-85. Miquel, J. et al., Eds. Boca Raton, FL: CRC Press.
2. Agarwal, R., Katiyar, S.K., Khan, S.G., and Mukhtar, H. 1993. Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem. Photobiol. 58: 695-700.
3. Berliner, J.A. and Heinecke, J. W. 1996. The role of oxidized lipoproteins in atherosclerosis. Free Rad. Biol. Med. 20: 707-727.
4. Bingham, S.A., Vorster, H., Jerling, J.C., Magee, L., Mulligan, A., Runswick, S., and Cummings, J.H. 1997. Effect of tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br. J. Nutr. 78: 41-55.
5. Boston Collaborative Surveillance Program. 1972. Coffee drinking and acute myocardial infarction. Lancet ii: 1278-1281.
6. Brown C.A., Bolton-Smith, C., Woodward, M., and Tunstall-Pedoe, H. 1993 Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Healthy Study. J. Epidemiol. Community Health 47: 171-175.
7. Busse, W.W., Kopp, D.E. and Middleton, E. 1984. Flavonoid modulation of human neutrophil function. J. Allergy Clin. Immunol. 73: 801-809.
8. Carson, C.A., Cauley, J.A., and Caggiula, A.W. 1993. Relation of caffeine intake to blood lipids in elderly women. Am. J. Epidemiol. 138: 94-100.
9. Chang, W.-C. and Hsu, F.-L. 1991. Inhibition of platelet activation and endothelial cell injury by flavan-3-ol and saikosaponin compounds. Prostaglandins Leukotrienes and Essential Fatty Acids 44: 51-56.
10. Chisaka, T., Matsuda, H., Kubomura, Y., Mochizuki, M., Yamahara, J., and Fujimura, H. 1988. Chem. Pharm. Bull. 36: 227-233.
11. Demrow, H.S., Slane, P.R., and Folts, J.D. 1995. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91: 1182-1188.
12. Duarte, J., Perez Viscaino, F., Utrilla, P., Jimenez, J., Tamargo, J., and Zarzuelo, A. 1993. Gen. Pharmacol. 24: 857-862.
13. Ferrandiz, M.L. and Alcaraz, M.J. 1991. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Ag. Act. 32: 283-288.
14. Folts, J.D. 1982. Experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance. Cardiovasc. Rev. Rep. 3(3): 370-382.
15. Folts, J.D. and Bonebrake, F.C. 1982. The effects of cigarette smoke and nicotine on platelet plugging in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 65: 465-469.
16. Folts J.D. An in vivo model of experimental arterial stenosis, intimai damage, and periodic thrombosis. Circulation Suppl. IV 83: 3-14.
17. Folts, J.D., Crowell, E.B. and Rowe, G.G. 1976. Platelet aggregation in partially obstructed vessels and their elimination with aspirin. Circulation 54: 365-370.
18. Folts, J.D. 1996. Flavonoids in tea but not coffee given by gastric tube inhibit in vivo platelet activity and thrombus formation in stenosed dog coronary arteries. FASEB J. 10: A793, #4579.
19. Formica, J. V. and Regelson, W. 1995. Review of the biology of quercetin and related bioflavonoids. Food. Chem. Toxic. 33: 1061-1080.
20. Frei, B. 1995. Cardiovascular disaese and nutrient antioxidants: role of low density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr. 35: 83-98.
21. Fuster, V. 1994. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90: 2126-2146.
22. Fu-quing, L., Mei-fang, Z., Xiao-gang, Z., Ji-min, L., and Wei-long, Y. 1989. A study on tea-pigment in prevention of atherosclerosis. Chin. Med. J. 102: 579-583.
23. Gerritsen, M.E., Carley, W.W., Ranges, G.E., Shen, C-P., Phan, S.A., Ligon, G.F., and Perry, C.A. 1995. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am. J. Pathol. 147: 278-292.
24. Gey, K.F. 1995. Ten-year retrospective on the antioxidant hypothesis of atherosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J. Nutr. Biochem. 6: 206-236.
25. Graham, H.N. 1992. Green tea composition, consumption and polyphenol chemistry. Prev. Med. 21: 334-350.
26. Green, M. and Jucha, E. 1986. Association of serum lipids with coffee, tea and egg consumption in free-living subjects. J. Epidemiol. Community Health 40: 324-329.
27. Green, M. and Harari, G. 1992. Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS study. Prev. Med. 21: 532-545.
28. Gryglewski, R.J., Robak, J., and Swies, J. 1985. In: Drugs Affecting Leukotrienes and Other Eicosanoid Pathways. pp. 149. Samuelsson, B., Berti, F., Folco G.C., and Velo, G.P., Eds., Plenum Press, New York.
29. Gryglewski, R.J., Korbut, R., Robak, J., and Swies, J. 1987. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 36: 317-322.
30. Hamet, P., Tremblay, J., and Sugimoto, H. 1985. Platelets in hypertension and peripheral vascular disease. In: The Platelets: Physiology and Pharmacology. pp. 367-381. Longnecker, G.L., Ed., Academic Press, New York.
31. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., and Kromhout, D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011.
32. Hertog, M.G.L., Feskens, E.J.M., and Kromhout D. 1997a. Antioxidant flavonols and coronary heart disease risk. Lancet 349: 699.
33. Hertog, M.G.L., Sweetnam, P.M., Fehily, A.M., Elwood, P.C., and Kromhout, D. 1997b. Antioxidant flavonols and ischaemic heart disease in a Welsh population of men. The Caerphilly Study. Am. J. Clin. Nutr. 65: 1489-1494.
34. Hof, K.H. van het, de Boer, H.S.M., Wiseman, S.A., Weststrate, J.A., and Tijburg, L.B.M. 1997. Consumption of green tea or black tea does not increase the resistance of LDL to oxidation in humans. Am. J. Clin. Nutr., 66: 1125-1132.
35. Hollman, P.C.H., Tijburg, L.B.M. and Yang, C.S. 1997. Bioavailability of flavonoids from tea. Crit. Rev. Food Sci. Nutr. (this issue).
36. Ikeda, I., Imasato, Y., Sasaki, E., Nakayama, M., Nagao, H., Takeo, T., Yayabe, F., and Sugano, M. 1992. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim. Biophys. Acta 1127: 141-146.
37. Imai, K. and Nakachi, K. 1995. Cross-sectional study of the effects of drinking green tea on cardiovascular and liver diseases. Br. Med. J. 310: 693-696.
38. Ishikawa, T., Suzukawa, M., Toshimitsu, I., Yoshida, H., Ayaori, M., Nishiwaki, M., Yonemura, A., Hara, Y., and Nakamura, H. 1997. Effect of Tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 66: 261-266.
39. Iso, H., Jacobs, D.R., Wentworth, D.N., Neaton, J.D., and Cohen, J.D. 1989. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med. 320: 904-910.
40. Janssen, P.L.T.M.K., Mensink, R.P., Cox, F.J.J., Harryvan, J.L., Hovenier, R., Hollman, P.C.H., and Katan, M.B. Effects of the flavonoids quercetin and apigenin on haemostasis in healthy volunteers: results from in vitro and a dietary supplement study. Am. J. Clin. Nutr., in press.
41. Jolles, B. and Harrison, R.G. 1966. Enzymatic processes and vascular changes in the skin radiation reaction. Br. J. Radiol. 39: 12.
42. Kark, J.D., Friedlander, Y., Kaufmann, N.A., and Stein, Y. 1985. Coffee, tea and plasma cholesterol: the Jerusalem Lipid Clinic prevalence study. Br. Med .J. 291: 699-704.
43. Katiyar, S.K., Agarwal, R., Wood, G.S., and Mukhtar, H. 1992. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction from green tea. Cancer Lett. 52: 6890-6897.
44. Katiyar, S.K., Rupp, C.O., Korman, N.J., Agarwal, R., and Mukhtar, H. 1995. Inhibition of 12-O-Tetradecanoyl-phorbol-13-Acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 mRNA and protein expression in SENCAR Mice by green tea polyphenols. J. Invest. Dermatol. 105: 394-398.
45. Keli, S.O., Hertog, M.G.L., Feskens, E.J.M., and Kromhout, D. 1996. Dietary flavonoids, antioxdant vitamins, and incidence of stroke. Arch. Intern. Med. 154: 637-642.
46. Kenny, M.T., Balistreri, F.J., and Torney, H.L. 1990. Flavonoid modulation of murine neutrophil cytokinesis. Immunopharm. Immunotoxicol. 12: 527-541.
47. Klatsky, A.L., Armstrong, M.A., and Friedman, G.D. 1993. Coffee, tea and mortality. Ann. Epidemiol. 3: 375-381.
48. Klatsky, A.L., Friedman, G.D., and Armstrong, M.A. 1990. Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. Am. J. Epidemiol. 132: 479-488.
49. Knekt, P., Järvinen, R., Reunanen, A., and Maatela, J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312: 478-481.
50. Kono, S., Shinchi, K., Ikeda, N., Yanai, F., and Imanishi, K. 1992. Green tea consumption and serum lipid profiles: a cross-sectional study in Northern Kyushi, Japan. Prev. Med. 21: 526-531.
51. Landolfi, R., Mower, R.L., and Steiner, M. 1984. Modification of platelet function and arachidonic acid by bioflavonoids. Structure-activity relations. Biochem. Pharmacol. 33: 1525-1530.
52. Luo, M., Wahlqvist, M.L., and O'Brien, R.C. 1997. Inhibition of LDL oxidation by green tea extract. Lancet 349: 360-361.
53. Man, M.Y.C., Ho, C.T., and Huang, H.I. 1995. Effects of three dietary phytochemicals from tea, rosemary and tumeric on inflammation-induced nitrite production. Cancer Lett. 96: 23-29.
54. Mangiapane, H., Thomson, J., Salter, A., Brown, S., Bell, D., and White D. A. 1992. The inhibition of the oxidation of low-density lipoprotein by (+)catechin, a naturally occurring flavonoid. Biochem. Pharmacol. 43: 445-450.
55. Matsuda, H., Chisaka, T., Kubomura, Y., Yamahara, T., Sawada, T., Fujimara, H., and Kimura, H. 1986. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J. Ethnopharmacol. 17: 213-224.
56. Middleton, E., Jr. and Kandaswami, C. 1993. In: The Flavonoids: Advances in Research Since 1986. pp. 619-652. Harborne, J.B., Ed., Chapman & Hall, London.
57. Miller, N.J., Castellucio, C., Tijburg, L.B.M., and Rice-Evans, C. 1996. The antioxidant properties of theaflavins and their gallate esters - radical scavengers or metal chelators. FEBS Lett. 392: 40-44.
58. 2+-mediated oxidative modification of low-density lipoprotein. Biol. Pharm. Bull. 17: 1567-1572.
59. 2+-mediated oxidative modification of low-density lipoprotein. Biol. Pharm. Bull. 18: 1-4.
60. Muramatsu, K., Fukuyo, M., and Hara, Y. 1986. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32: 613-622.
61. Nègre-Salvayre, A., Alomar, Y., Troly, M., and Salvayre, R. 1991. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effects of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim. Biophys. Acta 1096: 291-300.
62. Nègre-Salvayre, A. and Salvayre, R. 1992. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Rad. Biol. Med. 12: 101-106.
63. Pietta, P., Simonetti, P., Roggi, C., Brusamolino, A., Pellegrini, N., Maccarini, L., and Testolin, G. 1996. Dietary flavonoids and oxidative stress. Special Publication of the Royal Chemical Society 181: 249-255.
64. Polette, A., Lemaitre, D., Lagarde, M., and Vericel, E. 1996. N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins. Thromb. Haemost. 75: 945-949.
65. Radouco-Thomas, S., Grumbach, P., Nosal, G., and Radouco-Thomas, C. 1964. Life Sci. 3: 459-464.
66. Renaud, S., Morazain, R., Godsey, F., et al. 1986. Nutrients, platelet function and composition in nine groups of French and British farmers. Atherosclerosis 60: 37-48.
67. Rimm, E.B., Katan, M.B., Ascherio, A., Stampfer, M.J., and Willett, W.C. 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med. 125: 384-389.
68. Robak, J., Shridi, F., Wolbis, M., Krolikowska, M., and Sol, J. 1988. Screening of the influence of flavonoids on lipoxygenase and cycloxygenase activity as well as on non-enzymatic lipid oxidation. Pharmacol. Pharm. 40: 451-458.
69. Sageska-Mitane, Y., Miwa, M., and Okada, S. 1990. Platelet aggregation inhibitors in hot water extract of green tea. Chem. Pharm. Bull. 38: 790-793.
70. Sakagami, H., Asano, K., Hara, Y., and Shimamura, T. 1992. Stimulation of human monocyte and polymorphonuclear cell iodination and interleukin-1 production by epigallocatechin gallate. J. Leukocyt. Biol. 51: 478-483.
71. Salah, N., Miller, N.J., Paganga, G., Tijburg, L., Bolwell, G.P., and Rice-Evans, C. 1995. Polyphenolic flavonoids as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322: 339-346.
72. Schwartz, C.J., Valente, A.J., Sprague, E.A., Kelley, J.L., and Nerem, R.M. 1991. The pathogenesis of atherosclerosis: an overview. Clin. Cardiol. 14: 1-16.
73. Schwarz, B., Bischof, H.P., and Kunze, M. 1994. Coffee, tea, and lifestyle. Prev. Med. 23: 377-384.
74. Slane, P.R., Qureshi, A.A., and Folts, J.D. 1994. Platelet inhibition in stenosed canine arteries by quercetin and rutin, polyphenolic flavonoids found in red wine. Clin. Res. 42: 162A.
75. Stagg, G.V. and Millin, D.J. 1975. The nutritional and therapeutic value of tea - a review. J. Sci. Food Agric. 26: 1439-1459.
76. Stensvold, I., Tverdal, A., Solvoll, K., and Foss, O.P. 1992. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med. 21: 546-553.
77. Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., Mitchinson, M.J., and Brown, M.J. 1996. Randomized controlled trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet 347: 781-786.
78. Tijburg, L.B.M., Wiseman, S.A., Meijer, G.W., and Weststrate, J.A. 1997. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolemic rabbits. Atherosclerosis, 135: 37-47.
79. Tsubono, Y and Tsugane, S. 1997. Green take intake in relation to serum lipid levels in middle-aged Japanese men and women. Ann. Epidemiol. 7: 280-284.
80. Uchida, S., Ozaki, M., Akashi, T., Yamashita, K., Niwa, M., and Taniyama, K. 1995. Effects of epigallocatechin-3-o-gallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 1: S302-S303.
81. Urgert, R. and Katan, M.B. 1997. The cholesterol-raising factor from coffee beans. Annu. Rev. Nutr. 17: 305-324.
82. Valsa, A.K., Ushakumari, B., and Vijayalakshmi, N.P. 1995. Effect of catechin on lipid metabolism. J. Clin. Biochem. Nutr. 19: 175-182.
83. Vinson, J.A., Jang, J., Dabbagh Y.A., Serry, M.M., and Cai, S. 1995. Plant polyphenols exhibit lipoprotein bound antioxidant activity using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 43: 2798-2799.
84. Vinson, J.A., Dabbagh, Y.A., Serry, M.M., and Jang, J. 1995. Plant flavonoids, especially tea flavonoids, are powerful antioxidants using an in vitro model for heart disease. J. Agric. Food Chem. 43: 2800-2802.
85. Vorster, H., Jerling, J., Oosthuizen, W., Cummings, J., Bingham, S., Magee, L., Mulligan, A., and Runswick S. 1996. Tea drinking and haemostasis: a randomized, placebo-controlled, crossover study in free-living subjects. Haemostasis 26: 58-64.
86. Wei, M., Macera, A., Hornung, C.A., and Blair, S.N. 1995. The impact of changes in coffeee consumption on serum cholesterol. J. Clin. Epidemiol. 48: 1189-1196.
87. Wiseman, S.A. Balentine, D., and Frei, B. 1997. Antioxidants in tea. Crit. Rev. Food Sci. (this issue).
88. Witztum, J.L. and Steinberg, D. 1991. Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 88: 785-792.
89. Woolf, N. and Davies, M.J. 1992. Interrelationship between atherosclerosis and thrombosis. In: Thrombosis in Cardiovascular Disorders. pp. 50-55. Fuster, V. and Verstraete, M., Eds., W.B. Saunders, Philadelphia.
90. Yokozawa, T, Oura, H., Sakanaka, S., Ishigaki, S., and Kim, M. 1994. Depressor effect of tannin in green tea on rats with renal hypertension. Biosci. Biotech. Biochem. 58: 855-858.
91. Yoshino, K., Hara, Y., Sano, M., and Tomita, I. 1994. Antioxidative effects of black tea theaflavins and thearubigins on lipid peroxidation of rat liver homogenates induced by tert-butylhydroperoxide. Biol. Pharm. Bull. 17: 146-149.
92. Young, W., Hotovec, R.L., and Romero, A.G. 1967. Tea and atherosclerosis. Nature 216: 1015-1016.
93. Zhenhua, D., Yuan, C., Mei, Z., and Yunzhong, F. 1991. Inhibitory effects of China green tea polyphenol on the oxidative modification of low-density lipoprotein by macrophages. Med. Sci. Res. 19: 767-768.